Stock listing
ANIP Stock Price, News, Filings & Events — Ani Pharmaceuticals, Inc.
Selected listing: ANIP · NASDAQ · USD · US
This page tracks Ani Pharmaceuticals, Inc.'s ANIP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ANIP:NASDAQ. ANIP:NASDAQ is the stock-level entry point for investors researching Ani Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ani Pharmaceuticals, Inc. is a public company traded under the ticker ANIP in the American market. The company has a market capitalization of approximately $1.77 billion. Ani Pharmaceuticals focuses on the development and commercialization of specialty pharmaceuticals.
- Ticker
- ANIP:NASDAQ
- Asset type
- Stock
- Market cap
- $1.73B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Ani Pharmaceuticals, Inc. ANIP:NASDAQ stock context
This page tracks Ani Pharmaceuticals, Inc.'s ANIP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ANIP:NASDAQ. ANIP:NASDAQ is the stock-level entry point for investors researching Ani Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ani Pharmaceuticals, Inc. is a public company traded under the ticker ANIP in the American market. The company has a market capitalization of approximately $1.77 billion. Ani Pharmaceuticals focuses on the development and commercialization of specialty pharmaceuticals.
Latest news from Ani Pharmaceuticals, Inc.
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
August 24, 2026
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
August 7, 2026
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
July 24, 2026
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
July 16, 2026
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluo...
July 13, 2026
Ani Pharmaceuticals, Inc. earnings calls
ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call
August 7, 2026 · Replay with transcript and chapters
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call
May 8, 2026 · Replay with transcript and chapters
ANI Pharmaceuticals, Inc. (ANIP) Q4 2025 Earnings Call
February 27, 2026 · Replay with transcript and chapters
ANI Pharmaceuticals, Inc. (ANIP) Q3 2025 Earnings Call
November 7, 2025 · Replay with transcript and chapters
ANI Pharmaceuticals, Inc. (ANIP) Q2 2025 Earnings Call
August 8, 2025 · Replay with transcript and chapters
ANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call
May 9, 2025 · Replay with transcript and chapters
Research Ani Pharmaceuticals, Inc.
Ani Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for ANIP:NASDAQ.
Ani Pharmaceuticals, Inc. company profile
View the public company page for Ani Pharmaceuticals, Inc. on 6ix.
Ani Pharmaceuticals, Inc. news
Read company news and market updates connected to Ani Pharmaceuticals, Inc..
Ani Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Ani Pharmaceuticals, Inc..
Alternate listings
A1W15D:LSX
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:GETTEX
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
A1W15D:LS
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:DUS
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
ANIP:BOATS
US · USD
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:FWB
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:MUN
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:SWB
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:TRADEGATE
DE · EUR
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.
BSFA:BX
CH · CHF
Alternate listing for Ani Pharmaceuticals, Inc.; the primary context on this page is ANIP:NASDAQ.